Prostate cancer remains one of the most common cancers among men, yet current screening tools often fail to distinguish between harmless and aggressive forms of the disease. This review highlights how ...
Prostate cancer is highly heterogeneous, ranging from slow-growing tumors to aggressive, life-threatening disease. Current diagnostic methods, such as prostate-specific antigen (PSA) testing and ...
More than 35,000 men in the United States die from prostate cancer each year. Now, a new study reveals the immune cell ...